首页 » 细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV103
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

http://www.biovector.net


ID   SU-CCS-1

AC   CVCL_B470

SY   Su-ccs-1; Su CCS-1; SU-CCS1

DR   ATCC; CRL-2971

DR   Cosmic; 1092866

RX   PubMed=6362860;

RX   PubMed=7753552;

RX   PubMed=12966428;

RX   PubMed=15150091;

RX   PubMed=16766266;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 12,14

ST   D7S820: 12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3745; Clear cell sarcoma of soft tissue

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-1

AC   CVCL_0538

SY   SUDHL1; SUDHL-1; SuDHL 1; Stanford University-Diffuse Histiocytic Lymphoma-1

DR   BTO; BTO:0005058

DR   CLO; CLO_0009160

DR   EFO; EFO_0005461

DR   MCCL; MCC:0000439

DR   ATCC; CRL-2955

DR   BioSample; SAMN03471710

DR   CCLE; SUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308303

DR   ChEMBL-Targets; CHEMBL2366200

DR   Cosmic; 909742

DR   Cosmic; 946364

DR   Cosmic; 1086003

DR   Cosmic; 1086367

DR   Cosmic; 1086753

DR   Cosmic; 1152235

DR   Cosmic; 1995646

DR   Cosmic; 2361379

DR   Cosmic-CLP; 909742

DR   DSMZ; ACC-356

DR   GDSC; 909742

DR   GEO; GSM887652

DR   GEO; GSM888744

DR   GEO; GSM1217155

DR   GEO; GSM1670482

RX   PubMed=83902;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=2525056;

RX   PubMed=3881165;

RX   PubMed=4140017;

RX   PubMed=8547074;

RX   PubMed=9738977;

RX   PubMed=11021758;

RX   PubMed=11494142;

RX   PubMed=15356658;

RX   PubMed=16596703;

RX   PubMed=22460905;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; COG; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,13

ST   D16S539: 11,12

ST   D18S51: 15

ST   D19S433: 12,16

ST   D21S11: 29,30

ST   D2S1338: 19,20

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   D8S1179: 11

ST   FGA: 21

ST   Penta D: 14

ST   Penta E: 11,15

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-10

AC   CVCL_1889

SY   SUDHL10; Sudhl10; SUDHL-10; SuDHL 10; Stanford University-Diffuse Histiocytic Lymphoma-10; DHL10

DR   EFO; EFO_0002354

DR   ATCC; CRL-2963

DR   BioSample; SAMN03471872

DR   CCLE; SUDHL10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 850207

DR   Cosmic; 1067460

DR   Cosmic; 1079257

DR   Cosmic; 1517644

DR   Cosmic; 1541914

DR   Cosmic; 1636685

DR   Cosmic; 2276343

DR   Cosmic; 2361377

DR   Cosmic-CLP; 1331033

DR   DSMZ; ACC-576

DR   GDSC; 1331033

DR   GEO; GSM380143

DR   GEO; GSM552468

DR   GEO; GSM887651

DR   GEO; GSM888743

DR   GEO; GSM1059808

DR   GEO; GSM1374904

DR   GEO; GSM1670483

DR   IGRhCellID; SUDHL10

RX   PubMed=83902;

RX   PubMed=177185;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=1465024;

RX   PubMed=3881165;

RX   PubMed=9738977;

RX   PubMed=8547074;

RX   PubMed=19278952;

RX   PubMed=19358282;

RX   PubMed=22460905;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~15-30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 10,11

ST   D16S539: 10,11

ST   D18S51: 17

ST   D21S11: 31

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 8

ST   FGA: 22,23

ST   Penta D: 9,11

ST   Penta E: 16,17

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-11

AC   CVCL_W958

SY   SUDHL11; Stanford University-Diffuse Histiocytic Lymphoma-11; DHL-11

RX   PubMed=83902;

RX   PubMed=3881165;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-12

AC   CVCL_W959

SY   SUDHL12; Stanford University-Diffuse Histiocytic Lymphoma-12; DHL-12

RX   PubMed=83902;

RX   PubMed=3881165;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-13

AC   CVCL_H736

SY   SUDHL13; Stanford University-Diffuse Histiocytic Lymphoma-13; DHL-13

RX   PubMed=3881165;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-14

AC   CVCL_W960

SY   SUDHL14; Stanford University-Diffuse Histiocytic Lymphoma-14; DHL-14

RX   PubMed=3881165;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-15

AC   CVCL_W961

SY   SUDHL15; Stanford University-Diffuse Histiocytic Lymphoma-15; DHL-15

RX   PubMed=3881165;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-16

AC   CVCL_1890

SY   SUDHL16; SUDHL-16; Stanford University-Diffuse Histiocytic Lymphoma-16; DHL-16

DR   EFO; EFO_0002355

DR   ATCC; CRL-2964

DR   BioSample; SAMN03472751

DR   Cosmic; 1070713

DR   Cosmic-CLP; 1331034

DR   DSMZ; ACC-577

DR   GDSC; 1331034

DR   GEO; GSM380144

DR   GEO; GSM1670484

DR   IGRhCellID; SUDHL16

DR   IZSLER; BS TCL 226

RX   PubMed=19278952;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Peritoneal effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 11,13

ST   D18S51: 12,13

ST   D21S11: 30,31

ST   D3S1358: 14

ST   D5S818: 10

ST   D7S820: 9,10

ST   D8S1179: 12

ST   FGA: 20,21

ST   Penta D: 10,13

ST   Penta E: 13

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-18

AC   CVCL_9551

SY   SUDHL-18; Stanford University-Diffuse Histiocytic Lymphoma-18

DR   Cosmic; 1295513

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SU-DHL-2

AC   CVCL_9550

SY   SUDHL2; SUDHL-2; Su-DHL-2; SU-DHL2; SuDHL 2; Stanford University-Diffuse Histiocytic Lymphoma-2; DHL-2

DR   EFO; EFO_0007611

DR   ATCC; CRL-2956

DR   Cosmic; 1289989

DR   Cosmic; 1486588

DR   Cosmic; 1517653

DR   Cosmic; 1550339

DR   Cosmic; 1636686

DR   Cosmic; 2361374

DR   GEO; GSM1374905

RX   PubMed=83902;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=4140017;

RX   PubMed=8547074;

RX   PubMed=15356658;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Peritoneal effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 14

ST   D5S818: 13

ST   D7S820: 11,13

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-3

AC   CVCL_W769

SY   SU-DHL-3 (clone 1); Stanford University-Diffuse Histiocytic Lymphoma-3; DHL-3

RX   PubMed=83902;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=4140017;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-4

AC   CVCL_0539

SY   SUDHL4; Sudhl4; SUDHL-4; SuDHL 4; SUD4; SUD-4; SU4; Stanford University-Diffuse Histiocytic Lymphoma-4; DHL-4; DHL4

DR   BTO; BTO:0004076

DR   EFO; EFO_0006492

DR   MCCL; MCC:0000440

DR   ATCC; CRL-2957

DR   BioSample; SAMN03473232

DR   CCLE; SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308053

DR   ChEMBL-Targets; CHEMBL613711

DR   Cosmic; 850203

DR   Cosmic; 932763

DR   Cosmic; 999780

DR   Cosmic; 1067443

DR   Cosmic; 1079254

DR   Cosmic; 1517656

DR   Cosmic; 1541909

DR   Cosmic; 1636687

DR   Cosmic; 1714160

DR   Cosmic; 1945192

DR   Cosmic; 2276338

DR   Cosmic; 2361375

DR   Cosmic; 2437313

DR   Cosmic-CLP; 1331035

DR   DSMZ; ACC-495

DR   GDSC; 1331035

DR   GEO; GSM380145

DR   GEO; GSM499735

DR   GEO; GSM552463

DR   GEO; GSM887653

DR   GEO; GSM888745

DR   GEO; GSM1374906

DR   GEO; GSM1670485

DR   ICLC; HTL10002

DR   Lonza; 270

DR   PRIDE; PXD000589

RX   PubMed=83902;

RX   PubMed=177185;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=2875799;

RX   PubMed=3881165;

RX   PubMed=8547074;

RX   PubMed=9738977;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=23292937;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=25894527;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Cell surface proteome.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

CC   Discontinued: ICLC; HTL10002; true.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 14,16

ST   D21S11: 29,30

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 13

ST   FGA: 19,21

ST   Penta D: 9,14

ST   Penta E: 7,11

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 18,19

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-5

AC   CVCL_1735

SY   SUDHL5; SUDHL-5; SU-DH-L5; SuDHL 5; Stanford University-Diffuse Histiocytic Lymphoma-5; DHL-5; DHL5

DR   EFO; EFO_0002356

DR   ATCC; CRL-2958

DR   BioSample; SAMN03472762

DR   CCLE; SUDHL5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 850204

DR   Cosmic; 1079255

DR   Cosmic; 1517657

DR   Cosmic; 1541910

DR   Cosmic; 2276339

DR   Cosmic; 2361380

DR   Cosmic; 2437314

DR   Cosmic-CLP; 1331036

DR   DSMZ; ACC-571

DR   GDSC; 1331036

DR   GEO; GSM1962

DR   GEO; GSM380146

DR   GEO; GSM552464

DR   GEO; GSM887654

DR   GEO; GSM888746

DR   GEO; GSM1151287

DR   GEO; GSM1374907

DR   GEO; GSM1670486

DR   IGRhCellID; SUDHL5

RX   PubMed=83902;

RX   PubMed=177185;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=8547074;

RX   PubMed=10676951;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 11,13

ST   D18S51: 13,15

ST   D21S11: 28,30

ST   D3S1358: 15,16

ST   D5S818: 12,15

ST   D7S820: 10

ST   D8S1179: 13,15

ST   FGA: 22,23

ST   Penta D: 11,12

ST   Penta E: 5,19

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-6

AC   CVCL_2206

SY   SUDHL6; SuDHL6; SU-DHL6; SUDHL-6; SuDHL-6; SUD6; Stanford University-Diffuse Histiocytic Lymphoma-6; DHL-6; DHL6

DR   EFO; EFO_0002357

DR   ATCC; CRL-2959

DR   BioSample; SAMN03471138

DR   CCLE; SUDHL6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 687854

DR   Cosmic; 850205

DR   Cosmic; 1070712

DR   Cosmic; 1329089

DR   Cosmic; 1517640

DR   Cosmic; 1541911

DR   Cosmic; 1629935

DR   Cosmic; 1636688

DR   Cosmic; 1714158

DR   Cosmic; 2276340

DR   Cosmic; 2297009

DR   Cosmic; 2437315

DR   Cosmic-CLP; 1331037

DR   DSMZ; ACC-572

DR   ENCODE; ENCBS107PVI

DR   ENCODE; ENCBS136LHJ

DR   ENCODE; ENCBS401ZBX

DR   GDSC; 1331037

DR   GEO; GSM1955

DR   GEO; GSM115975

DR   GEO; GSM201348

DR   GEO; GSM380147

DR   GEO; GSM552465

DR   GEO; GSM887655

DR   GEO; GSM888747

DR   GEO; GSM1374908

DR   GEO; GSM1670487

DR   IGRhCellID; SUDHL6

DR   Lonza; 455

DR   PRIDE; PXD000589

RX   PubMed=83902;

RX   PubMed=177185;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=7849311;

RX   PubMed=9738977;

RX   PubMed=10676951;

RX   PubMed=16960149;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=23699601;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=25894527;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=4672

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~35-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Cell surface proteome.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

CC   Derived from metastatic site: Peritoneal cavity.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,14

ST   D16S539: 11,12

ST   D18S51: 12,13

ST   D21S11: 29

ST   D3S1358: 14,17

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 14

ST   FGA: 20,24

ST   Penta D: 8,10

ST   Penta E: 5,12

ST   TH01: 6,9.3

ST   TPOX: 11,12

ST   vWA: 14,17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-7

AC   CVCL_4380

SY   SUDHL7; SUDHL-7; SuDHL 7; Stanford University-Diffuse Histiocytic Lymphoma-7; DHL-7; DHL7

DR   Cosmic; 850206

DR   Cosmic; 1290018

DR   Cosmic; 1517608

DR   Cosmic; 1541912

DR   Cosmic; 1945193

DR   Cosmic; 2276341

DR   Cosmic; 2361373

DR   GEO; GSM380148

DR   GEO; GSM552466

RX   PubMed=83902;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=8547074;

RX   PubMed=19278952;

RX   PubMed=19358282;

RX   PubMed=23292937;

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: miRNA expression profiling.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DHL-8

AC   CVCL_2207

SY   SUDHL8; SUDHL-8; SuDHL 8; Stanford University-Diffuse Histiocytic Lymphoma-8; DHL-8; DHL8

DR   EFO; EFO_0006493

DR   ATCC; CRL-2961

DR   BioSample; SAMN03471060

DR   CCLE; SUDHL8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1067442

DR   Cosmic; 1079256

DR   Cosmic; 1295511

DR   Cosmic; 1517639

DR   Cosmic; 1541913

DR   Cosmic; 1636689

DR   Cosmic; 2276342

DR   Cosmic; 2361381

DR   Cosmic; 2437316

DR   Cosmic-CLP; 1331038

DR   DSMZ; ACC-573

DR   GDSC; 1331038

DR   GEO; GSM380149

DR   GEO; GSM552467

DR   GEO; GSM887656

DR   GEO; GSM888748

DR   GEO; GSM1374909

DR   GEO; GSM1670488

RX   PubMed=83902;

RX   PubMed=177185;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=8547074;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~48-72 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

CC   Derived from metastatic site: Peritoneal effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D16S539: 12

ST   D18S51: 14,19

ST   D21S11: 30,31.2

ST   D3S1358: 14,15

ST   D5S818: 11,13

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 25

ST   Penta D: 11,12

ST   Penta E: 14,17

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DHL-9

AC   CVCL_4379

SY   SUDHL9; SUDHL-9; SuDHL 9; Stanford University-Diffuse Histiocytic Lymphoma-9; DHL-9; DHL9

DR   BTO; BTO:0001617

DR   Cosmic; 2361382

DR   GEO; GSM380150

RX   PubMed=83902;

RX   PubMed=177185;

RX   PubMed=214220;

RX   PubMed=371794;

RX   PubMed=3881165;

RX   PubMed=8547074;

RX   PubMed=9738977;

RX   PubMed=19278952;

RX   PubMed=23699601;

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Genome sequenced.

CC   Omics: miRNA expression profiling.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DIPG-IV

AC   CVCL_IT39

SY   SUDIPGIV; SUDIPG4

RX   PubMed=25939062;

CC   Characteristics: Has a HIST1H3B p.Lys28Met mutation (H3.1K27M).

CC   Omics: Deep RNAseq analysis.

ST   Source(s): PubMed=25939062

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 7,12

ST   D16S539: 9,12

ST   D21S11: 29,31

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DIPG-VI

AC   CVCL_IT40

SY   SUDIPGVI; DIPG-6

RX   PubMed=24777482;

RX   PubMed=25939062;

WW   http://mckennaclairefoundation.org/

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Omics: Deep RNAseq analysis.

CC   Miscellaneous: Established from a sample taken just after the death at age 7 of McKenna Wetzel. When McKenna died, the Wetzels donated to researchers at Stanford University the tissues that allowed this cell line to be derived. They also created the McKenna Claire Foundation's whose mission is to help cure pediatric brain cancer by raising awareness, increasing community involvement and funding research.

ST   Source(s): PubMed=25939062

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 8,13

ST   D21S11: 29,31

ST   D5S818: 10,12

ST   D7S820: 8,9

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DIPG-XIII

AC   CVCL_IT41

SY   SU DIPG XIII; SU-DIPGXIII

RX   PubMed=25939062;

RX   PubMed=26115193;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

ST   Source(s): PubMed=25939062

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D21S11: 30

ST   D5S818: 12

ST   D7S820: 9

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 13,18

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DUL-1

AC   CVCL_IV41

SY   Stanford University-Diffuse Undifferentiated Lymphoma-1

RX   PubMed=83902;

RX   PubMed=6804087;

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-DUL-2

AC   CVCL_IV42

SY   Stanford University-Diffuse Undifferentiated Lymphoma-2

RX   PubMed=83902;

RX   PubMed=6804087;

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU-DUL-3

AC   CVCL_IV43

SY   Stanford University-Diffuse Undifferentiated Lymphoma-3

RX   PubMed=83902;

RX   PubMed=6804087;

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU-LB-1

AC   CVCL_IV34

SY   Stanford University-LymphoBlastoid-1

RX   PubMed=83902;

RX   PubMed=4140017;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SU-LB-2

AC   CVCL_IV35

SY   Stanford University-LymphoBlastoid-2

RX   PubMed=83902;

RX   PubMed=174098;

RX   PubMed=214220;

RX   PubMed=371794;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SU-LB-3

AC   CVCL_IV36

SY   Stanford University-LymphoBlastoid-3

RX   PubMed=83902;

RX   PubMed=214220;

RX   PubMed=371794;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SU-LB-4

AC   CVCL_IV37

SY   Stanford University-LymphoBlastoid-4

RX   PubMed=83902;

RX   PubMed=174098;

RX   PubMed=214220;

RX   PubMed=371794;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SU-LB-5

AC   CVCL_IV38

SY   Stanford University-LymphoBlastoid-5

RX   PubMed=83902;

RX   PubMed=174098;

RX   PubMed=214220;

RX   PubMed=371794;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SU-pcGBM-2

AC   CVCL_IT42

SY   SU-pcGBM2

RX   PubMed=25939062;

ST   Source(s): PubMed=25939062

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 9,11

ST   D21S11: 28,30.2

ST   D5S818: 11

ST   D7S820: 11,12

ST   TH01: 9.3

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU/RH-HD-1

AC   CVCL_M692

SY   SU/RH-HD1

RX   PubMed=2690233;

RX   PubMed=6332936;

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SU.86.86

AC   CVCL_3881

SY   SU 86.86; SU-86-86; Su-86-86; SU86.86; SU86-86; SU86_86; Su86_86; SU8686; SU.86

DR   BTO; BTO:0001904

DR   CLO; CLO_0009150

DR   EFO; EFO_0006494

DR   ATCC; CRL-1837

DR   BioSample; SAMN03472014

DR   CCLE; SU8686_PANCREAS

DR   CGH-DB; 183-1

DR   CGH-DB; 9282-4

DR   Cosmic; 707252

DR   Cosmic; 868244

DR   Cosmic; 873003

DR   Cosmic; 913314

DR   Cosmic; 922250

DR   Cosmic; 923172

DR   Cosmic; 932522

DR   Cosmic; 949237

DR   Cosmic; 1006362

DR   Cosmic; 1066203

DR   Cosmic; 1122349

DR   Cosmic; 1218879

DR   Cosmic; 1358486

DR   Cosmic; 1518237

DR   Cosmic; 1644315

DR   Cosmic; 1995645

DR   Cosmic; 2434090

DR   Cosmic-CLP; 1240218

DR   GDSC; 1240218

DR   GEO; GSM206545

DR   GEO; GSM621901

DR   GEO; GSM784693

DR   GEO; GSM887650

DR   GEO; GSM888742

DR   GEO; GSM1024414

DR   GEO; GSM1374903

DR   GEO; GSM1670481

DR   IZSLER; BS TCL 180

DR   PRIDE; PXD003198

DR   SKY/M-FISH/CGH; 2000

RX   PubMed=3264833;

RX   PubMed=10027410;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=18380791;

RX   PubMed=20418756;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SU.86.86

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 48 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'Su_86_96' in Cosmic 913314.

CC   Misspelling: 'SU-88-86' in Cosmic 873003.

CC   Derived from metastatic site: Liver.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 9

ST   D21S11: 30

ST   D3S1358: 14,19

ST   D5S818: 7,13

ST   D7S820: 8,11

ST   D8S1179: 12,15

ST   FGA: 21,22

ST   Penta D: 9,13

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SU511

AC   CVCL_W082

SY   Su511

DR   Cosmic; 1522784

DR   GEO; GSM726284

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SU706A

AC   CVCL_S719

DR   SKY/M-FISH/CGH; 3861

DI   NCIt; C6339; Uterine corpus sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Sua1.1

AC   CVCL_Z626

DR   BTO; BTO:0002635

RX   PubMed=12626708;

CC   Group: Insect cell line.

CC   Breed/subspecies: Suakoko 2La.

OX   NCBI_TaxID=7165; ! Anopheles gambiae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Sua1B

AC   CVCL_Z627

SY   SuaB.1

RX   PubMed=9326640;

RX   PubMed=23382679;

RX   PubMed=23891577;

WW   http://kafatos.openwetware.org/Instructions_for_Anopheles_gambiae_cell_lines.html

CC   Group: Insect cell line.

CC   Breed/subspecies: Suakoko 2La.

OX   NCBI_TaxID=7165; ! Anopheles gambiae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Sua4.0

AC   CVCL_Z629

SY   Sua 4.0; Suakoko 4

RX   PubMed=10681436;

RX   PubMed=23382679;

WW   http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-921.aspx

WW   https://www.vectorbase.org/data/anopheles-gambiae-sua-40-cell-line-avcl

CC   Group: Insect cell line.

CC   Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-921.

CC   Omics: Deep RNAseq analysis.

CC   Breed/subspecies: Suakoko 2La.

OX   NCBI_TaxID=7165; ! Anopheles gambiae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Sua5.1*

AC   CVCL_Z630

SY   Sua 5.1*; Sua 5.1

RX   PubMed=10681436;

RX   PubMed=23382679;

WW   http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-922.aspx

WW   https://www.vectorbase.org/data/anopheles-gambiae-sua-51-cell-line-avcl

CC   Group: Insect cell line.

CC   Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-922.

CC   Omics: Deep RNAseq analysis.

CC   Breed/subspecies: Suakoko 2La.

OX   NCBI_TaxID=7165; ! Anopheles gambiae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SuaE.1

AC   CVCL_Z628

SY   SuaE1; SuaE

RX   PubMed=23382679;

WW   http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-924.aspx

WW   https://www.vectorbase.org/data/anopheles-gambiae-suae1-cell-line-avcl

CC   Group: Insect cell line.

CC   Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-924.

CC   Omics: Deep RNAseq analysis.

CC   Breed/subspecies: Suakoko 2La.

OX   NCBI_TaxID=7165; ! Anopheles gambiae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Subclone 707 BUF

AC   CVCL_4309

DR   CLO; CLO_0009151

DR   CLDB; cl4411

DR   ECACC; 91112122

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP1

AC   CVCL_8918

SY   707 DAP1

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP10

AC   CVCL_8919

SY   707 DAP10

DR   CLO; CLO_0001466

DR   CLDB; cl121

DR   ECACC; 91112130

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112130; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP2

AC   CVCL_8920

SY   707 DAP2

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP3

AC   CVCL_8921

SY   707 DAP3

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP4

AC   CVCL_8922

SY   707 DAP4; 707DAP4

RX   PubMed=3116422;

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP5

AC   CVCL_8923

SY   707 DAP5

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP6

AC   CVCL_8924

SY   707 DAP6

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP7

AC   CVCL_8925

SY   707 DAP7

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP8

AC   CVCL_4310

SY   707 DAP8

DR   CLO; CLO_0009152

DR   CLDB; cl4412

DR   ECACC; 91112129

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DAP9

AC   CVCL_4Y34

SY   707 DAP9

RX   PubMed=3477692;

CC   Selected for resistance to: ChEBI; CHEBI:38001; 2,6-diaminopurine (2,6-DAP).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DK 4.8

AC   CVCL_8291

DR   CLO; CLO_0009153

DR   CLDB; cl4413

DR   ECACC; 91112119

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112119; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DKA

AC   CVCL_8292

DR   CLO; CLO_0009154

DR   CLDB; cl4414

DR   ECACC; 91112117

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112117; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DKE

AC   CVCL_8293

DR   CLO; CLO_0009155

DR   CLDB; cl4415

DR   ECACC; 91112132

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112132; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DKH

AC   CVCL_8294

DR   CLO; CLO_0009156

DR   CLDB; cl4416

DR   ECACC; 91112131

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112131; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 DKJ

AC   CVCL_8295

DR   CLO; CLO_0009157

DR   CLDB; cl4417

DR   ECACC; 91112118

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112118; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 TG1

AC   CVCL_8296

DR   CLO; CLO_0009158

DR   CLDB; cl4418

DR   ECACC; 91112127

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112127; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   Subclone 707 TG2

AC   CVCL_8297

DR   CLO; CLO_0009159

DR   CLDB; cl4419

DR   ECACC; 91112128

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Discontinued: ECACC; 91112128; probable.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4145 ! Clone 707

CA   Cancer cell line

//

ID   SUBL

AC   CVCL_M554

RX   PubMed=7506636;

CC   Doubling time: ~48 hours (PubMed=7506636).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUHC-1

AC   CVCL_HE76

SY   Shinshu University Hepatocellular Carcinoma-1

RX   PubMed=1328123;

RX   PubMed=8280838;

RX   PubMed=9737568;

CC   Characteristics: Altough established from a patient suffering from persistent HCC infection, HCV-RNA is not detected.

CC   Characteristics: Has lost chromosome Y.

CC   Doubling time: ~24 hours (PubMed=1328123).

DI   NCIt; C3098; Hepatitis C infection

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUIT-2

AC   CVCL_3172

SY   Suit-2; SUIT 2; SUIT2

DR   BTO; BTO:0003493

DR   EFO; EFO_0006495

DR   BioSample; SAMN03472902

DR   CCLE; SUIT2_PANCREAS

DR   Cosmic; 710872

DR   Cosmic; 755300

DR   Cosmic; 808161

DR   Cosmic; 918051

DR   Cosmic; 1108340

DR   Cosmic; 1320464

DR   Cosmic; 1534322

DR   Cosmic; 1995647

DR   Cosmic-CLP; 1240219

DR   GDSC; 1240219

DR   GEO; GSM244426

DR   GEO; GSM244427

DR   GEO; GSM827218

DR   GEO; GSM887657

DR   GEO; GSM888749

DR   GEO; GSM1588615

DR   GEO; GSM1670489

DR   JCRB; JCRB1094

DR   TKG; TKG 0705

RX   PubMed=3102439;

RX   PubMed=11169959;

RX   PubMed=11787853;

RX   PubMed=12800145;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/SUIT-2.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 9

ST   D18S51: 16

ST   D21S11: 29,30

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 14,15

ST   FGA: 20,23

ST   Penta D: 11

ST   Penta E: 10

ST   TH01: 6

ST   TPOX: 8,10

ST   vWA: 16,17

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUIT-4

AC   CVCL_9280

RX   PubMed=15452375;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUIT-58

AC   CVCL_1Y17

RX   PubMed=26141632;

CC   Doubling time: 32 hours (PubMed=26141632).

CC   Derived from metastatic site: Liver.

ST   Source(s): PubMed=26141632

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,12

ST   D16S539: 9,11

ST   D21S11: 31

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Sulubo

AC   CVCL_IU22

RX   PubMed=4122458;

RX   PubMed=4364259;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SUM102PT

AC   CVCL_3421

SY   SUM-102PT; SUM 102PT; SUM-102; SUM 102; SUM102; Sum102; 102PT

DR   BTO; BTO:0005387

DR   Cosmic; 904388

DR   Cosmic; 997922

DR   Cosmic; 1046939

DR   Cosmic; 1287928

DR   Cosmic; 1289410

DR   GEO; GSM217598

DR   GEO; GSM350537

DR   GEO; GSM1008914

DR   GEO; GSM1215255

DR   GEO; GSM1401675

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=15677628;

RX   PubMed=19582160;

RX   PubMed=23601657;

RX   PubMed=24162158;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Omics: CNV analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM1315MO2

AC   CVCL_5589

SY   SUM1315M02; SUM1315-MO2; SUM-1315M02; SUM 1315M02; SUM-1315; SUM 1315; SUM1315; 1315M02

DR   BTO; BTO:0005933

DR   EFO; EFO_0001239

DR   BioSample; SAMN03471829

DR   Cosmic; 904394

DR   Cosmic; 997924

DR   Cosmic; 1046961

DR   Cosmic; 1287925

DR   Cosmic; 1289417

DR   Cosmic; 1460228

DR   GEO; GSM217599

DR   GEO; GSM1008915

DR   GEO; GSM1214566

DR   GEO; GSM1374910

DR   LINCS; 51081

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

CC   Part of: KuDOS 95 cell line panel.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Skin.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 12

ST   D21S11: 28,29

ST   D3S1358: 18

ST   D5S818: 13

ST   D7S820: 8,12

ST   D8S1179: 13,15

ST   FGA: 25

ST   Penta D: 13,15

ST   Penta E: 5

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM149-Luc

AC   CVCL_DH44

DR   GEO; GSM1463862

RX   PubMed=20229045;

RX   PubMed=25279830;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C4001; Inflammatory breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3422 ! SUM149PT

SX   Female

CA   Cancer cell line

//

ID   SUM149-Luc/MA1

AC   CVCL_DH45

SY   MA1

DR   GEO; GSM1463860

DR   GEO; GSM1463863

RX   PubMed=25279830;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C4001; Inflammatory breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH44 ! SUM149-Luc

SX   Female

CA   Cancer cell line

//

ID   SUM149-Luc/MA2

AC   CVCL_DH46

SY   MA2

DR   GEO; GSM1463861

DR   GEO; GSM1463864

RX   PubMed=25279830;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C4001; Inflammatory breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH44 ! SUM149-Luc

SX   Female

CA   Cancer cell line

//

ID   SUM149PT

AC   CVCL_3422

SY   SUM-149PT; SUM 149PT; SUM149; SUM-149; SUM 149; 149 PT; 149PT

DR   BTO; BTO:0005475

DR   EFO; EFO_0001240

DR   BioSample; SAMN03472959

DR   Cosmic; 1044208

DR   Cosmic; 1046959

DR   Cosmic; 1136379

DR   Cosmic; 1176631

DR   Cosmic; 1287929

DR   Cosmic; 1289411

DR   Cosmic; 1460239

DR   Cosmic; 1523966

DR   Cosmic; 1603224

DR   Cosmic; 2036674

DR   GEO; GSM115105

DR   GEO; GSM217600

DR   GEO; GSM350549

DR   GEO; GSM481335

DR   GEO; GSM501233

DR   GEO; GSM501234

DR   GEO; GSM501235

DR   GEO; GSM501237

DR   GEO; GSM501238

DR   GEO; GSM847433

DR   GEO; GSM847500

DR   GEO; GSM844705

DR   GEO; GSM1008916

DR   GEO; GSM1214568

DR   GEO; GSM1215280

DR   GEO; GSM1374911

DR   GEO; GSM1401669

DR   LINCS; 51082

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=15857504;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=26495931;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Part of: KuDOS 95 cell line panel.

CC   Omics: CNV analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 14,15

ST   D21S11: 28,31.2

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 14,16

ST   FGA: 29

ST   Penta D: 8,9

ST   Penta E: 11

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 16,18

DI   NCIt; C4001; Inflammatory breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM159PT

AC   CVCL_5423

AS   CVCL_5590

SY   SUM-159PT; SUM 159PT; SUM-159; SUM 159; SUM159; 159 PT; 159PT

DR   BTO; BTO:0004928

DR   EFO; EFO_0001241

DR   BioSample; SAMN03472960

DR   Cosmic; 904389

DR   Cosmic; 1046944

DR   Cosmic; 1136380

DR   Cosmic; 1287924

DR   Cosmic; 1289412

DR   Cosmic; 1460240

DR   GEO; GSM75170

DR   GEO; GSM217601

DR   GEO; GSM412074

DR   GEO; GSM412089

DR   GEO; GSM412092

DR   GEO; GSM412105

DR   GEO; GSM412114

DR   GEO; GSM412117

DR   GEO; GSM474278

DR   GEO; GSM474279

DR   GEO; GSM476481

DR   GEO; GSM476482

DR   GEO; GSM476483

DR   GEO; GSM478318

DR   GEO; GSM478319

DR   GEO; GSM478323

DR   GEO; GSM478324

DR   GEO; GSM847434

DR   GEO; GSM847501

DR   GEO; GSM844707

DR   GEO; GSM844706

DR   GEO; GSM967817

DR   GEO; GSM967822

DR   GEO; GSM1008917

DR   GEO; GSM1214567

DR   GEO; GSM1401652

DR   LINCS; 51083

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=11044355;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/SUM-159.html

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Microsatellite instability: Stable (MSS) (PubMed=15677628).

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'SUM152'.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 12,14

ST   D21S11: 28

ST   D3S1358: 11,16

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 11,13

ST   FGA: 21,22

ST   Penta D: 9,11

ST   Penta E: 17

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C5161; Pleomorphic breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM16LN

AC   CVCL_Y469

SY   SUM-16LN

RX   PubMed=8018955;

RX   PubMed=8425198;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SUM185PE

AC   CVCL_5591

SY   SUM-185PE; SUM 185PE; SUM-185; SUM 185; SUM185; 185PE

DR   BTO; BTO:0005476

DR   EFO; EFO_0001242

DR   Cosmic; 904390

DR   Cosmic; 1046940

DR   Cosmic; 1136381

DR   Cosmic; 1176642

DR   Cosmic; 1287898

DR   Cosmic; 1289413

DR   Cosmic; 1460241

DR   GEO; GSM847435

DR   GEO; GSM847502

DR   GEO; GSM844708

DR   LINCS; 51084

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=23601657;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4017; Ductal breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM190PT

AC   CVCL_3423

SY   SUM-190PT; SUM 190PT; SUM-190; SUM 190; SUM190; 190PT

DR   BTO; BTO:0005477

DR   EFO; EFO_0001243

DR   BioSample; SAMN03471033

DR   Cosmic; 904391

DR   Cosmic; 1046941

DR   Cosmic; 1287899

DR   Cosmic; 1289414

DR   Cosmic; 1460244

DR   Cosmic; 1603225

DR   GEO; GSM217602

DR   GEO; GSM350534

DR   GEO; GSM847436

DR   GEO; GSM847503

DR   GEO; GSM1008918

DR   GEO; GSM1215269

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=28196595;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: CNV analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 8,10

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 12

ST   D21S11: 28,30

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 10,15

ST   FGA: 22

ST   Penta D: 10,11

ST   Penta E: 18,19

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C4001; Inflammatory breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM206CWN

AC   CVCL_5592

SY   SUM-206CWN; SUM-206cwn; SUM206; SUM-206

RX   PubMed=10424408;

RX   PubMed=10604729;

WW   http://web.archive.org/web/20040421014855/http://www.cancer.med.umich.edu/breast_cell/Production/sumlines/SUM-206CWN.html

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SUM225CWN

AC   CVCL_5593

SY   SUM-225CWN; SUM-225cwn; SUM 225CWN; SUM-225; SUM 225; SUM225; Sum225; 225CWN

DR   BTO; BTO:0005478

DR   EFO; EFO_0001244

DR   Cosmic; 904392

DR   Cosmic; 1046960

DR   Cosmic; 1136359

DR   Cosmic; 1287900

DR   Cosmic; 1289415

DR   Cosmic; 1460242

DR   GEO; GSM320177

DR   GEO; GSM847437

DR   GEO; GSM847504

DR   GEO; GSM844709

DR   GEO; GSM844710

DR   LINCS; 51085

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=23601657;

RX   PubMed=28196595;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM229PE

AC   CVCL_5594

SY   SUM-229PE; SUM 229PE; SUM-229; SUM 229; SUM229; 229PE

DR   BTO; BTO:0005479

DR   EFO; EFO_0006762

DR   BioSample; SAMN03471035

DR   Cosmic; 904393

DR   Cosmic; 997923

DR   Cosmic; 1046949

DR   Cosmic; 1287930

DR   Cosmic; 1289416

DR   Cosmic; 1460243

DR   Cosmic; 1479523

DR   LINCS; 51086

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=15677628;

RX   PubMed=23601657;

RX   PubMed=25485619;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 13.3,14.3

ST   D19S433: 12,14

ST   D21S11: 28,31.2

ST   D2S1338: 20

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 14,16

ST   FGA: 29

ST   Penta D: 8,9

ST   Penta E: 11

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 16,18

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM44PE

AC   CVCL_3424

SY   SUM-44PE; SUM 44PE; SUM-44 PE; SUM-44; SUM 44; SUM44; Sum44; 44PE

DR   BTO; BTO:0005389

DR   EFO; EFO_0001245

DR   Cosmic; 997937

DR   Cosmic; 1289408

DR   Cosmic; 1460237

DR   GEO; GSM115108

DR   GEO; GSM217603

DR   GEO; GSM320179

DR   GEO; GSM350531

DR   GEO; GSM481300

DR   GEO; GSM847438

DR   GEO; GSM847505

DR   GEO; GSM1226542

DR   GEO; GSM1226543

DR   GEO; GSM1226544

DR   GEO; GSM1226545

DR   GEO; GSM1226546

DR   GEO; GSM1226547

DR   GEO; GSM1226548

DR   GEO; GSM1226549

DR   GEO; GSM1226550

DR   GEO; GSM1226551

DR   GEO; GSM1226552

DR   GEO; GSM1226553

DR   GEO; GSM1226554

DR   GEO; GSM1226555

DR   GEO; GSM1226556

DR   GEO; GSM1226557

DR   GEO; GSM1226558

DR   GEO; GSM1226559

DR   GEO; GSM1226560

DR   GEO; GSM1226561

DR   GEO; GSM1661990

RX   PubMed=8425198;

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=23601657;

RX   PubMed=24425047;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Omics: CNV analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C7950; Invasive lobular breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUM52PE

AC   CVCL_3425

SY   SUM-52PE; SUM 52PE; SUM-52-PE; SUM-52; SUM 52; SUM52; 52PE

DR   BTO; BTO:0005390

DR   EFO; EFO_0001246

DR   BioSample; SAMN03472911

DR   Cosmic; 904387

DR   Cosmic; 1046962

DR   Cosmic; 1176647

DR   Cosmic; 1287897

DR   Cosmic; 1289409

DR   Cosmic; 1460238

DR   GEO; GSM115109

DR   GEO; GSM217604

DR   GEO; GSM320178

DR   GEO; GSM350524

DR   GEO; GSM481330

DR   GEO; GSM847439

DR   GEO; GSM847506

DR   GEO; GSM844711

DR   GEO; GSM844712

DR   GEO; GSM1374912

DR   LINCS; 51087

RX   PubMed=10424408;

RX   PubMed=10604729;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=23601657;

RX   PubMed=25485619;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/SUM52.html

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=SUM-52PE

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Omics: CNV analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 10

ST   D18S51: 16

ST   D21S11: 27,28

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 14

ST   D8S1179: 13

ST   FGA: 21

ST   Penta D: 9,12

ST   Penta E: 13,17

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUNE1

AC   CVCL_6946

SY   SUNE-1; SUNE 1

DR   Cosmic; 755507

DR   Cosmic; 1193458

DR   Cosmic; 1322950

DR   Cosmic; 2366882

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SUNE2

AC   CVCL_6956

SY   SUNE-2

RX   PubMed=22176775;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-B1

AC   CVCL_A309

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SUP-B12

AC   CVCL_A319

RX   PubMed=2541219;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-B13

AC   CVCL_A308

SY   SUPB13

DR   Cosmic; 2348805

RX   PubMed=1967982;

RX   PubMed=3162827;

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0103 ! SUP-B15

SX   Male

CA   Cancer cell line

//

ID   SUP-B15

AC   CVCL_0103

SY   Sup-B15; SUPB-15; SUPB15; SupB15; SupB15W; SupB15WT

DR   CLO; CLO_0009161

DR   EFO; EFO_0006763

DR   ATCC; CRL-1929

DR   BCRJ; 0229

DR   BioSample; SAMN03473114

DR   CCLE; SUPB15_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1012120

DR   Cosmic; 1130245

DR   Cosmic; 1498420

DR   Cosmic; 1524821

DR   Cosmic; 1630017

DR   Cosmic; 2491077

DR   Cosmic-CLP; 1247871

DR   DSMZ; ACC-389

DR   GDSC; 1247871

DR   GEO; GSM236806

DR   GEO; GSM236842

DR   GEO; GSM887658

DR   GEO; GSM888750

DR   GEO; GSM1374913

DR   GEO; GSM1670490

DR   IZSLER; BS TCL 238

DR   PRIDE; PXD000394

RX   PubMed=3162827;

RX   PubMed=8704231;

RX   PubMed=9067587;

RX   PubMed=9108419;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25576301;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: HLA class I peptidome analysis by proteomics.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,14

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 28,31

ST   D3S1358: 15,16

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   D8S1179: 11,14

ST   FGA: 19,20

ST   Penta D: 9,12

ST   Penta E: 21

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A308 ! SUP-B13

SX   Male

CA   Cancer cell line

//

ID   SUP-B15/RI

AC   CVCL_S642

SY   SUP-B15-RI

DR   Cosmic; 1630018

RX   PubMed=22285507;

RX   PubMed=23230732;

CC   Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0103 ! SUP-B15

SX   Male

CA   Cancer cell line

//

ID   SUP-B16

AC   CVCL_A310

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A321 ! SUP-B19

SX   Female

CA   Cancer cell line

//

ID   SUP-B17

AC   CVCL_A322

RX   PubMed=2541219;

RX   PubMed=8231254;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-B19

AC   CVCL_A321

AS   CVCL_A311

RX   PubMed=8231254;

RX   PubMed=8704231;

CC   Misspelling: 'SUP-B18' in PubMed=8704231.

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A310 ! SUP-B16

SX   Female

CA   Cancer cell line

//

ID   SUP-B2

AC   CVCL_A312

RX   PubMed=2875799;

RX   PubMed=8231254;

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-B24

AC   CVCL_A313

RX   PubMed=8231254;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A317 ! SUP-B31

SX   Female

CA   Cancer cell line

//

ID   SUP-B26

AC   CVCL_A314

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A316 ! SUP-B28

SX   Male

CA   Cancer cell line

//

ID   SUP-B27

AC   CVCL_A315

DR   Cosmic; 2396140

DR   Cosmic; 2491078

RX   PubMed=1967982;

RX   PubMed=8231254;

RX   PubMed=8704231;

RX   PubMed=9067587;

RX   PubMed=10490826;

DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-B28

AC   CVCL_A316

RX   PubMed=8231254;

RX   PubMed=8704231;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A314 ! SUP-B26

SX   Male

CA   Cancer cell line

//

ID   SUP-B31

AC   CVCL_A317

RX   PubMed=8231254;

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A313 ! SUP-B24

SX   Female

CA   Cancer cell line

//

ID   SUP-B6

AC   CVCL_A320

RX   PubMed=2875799;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SUP-B7

AC   CVCL_A318

RX   PubMed=3469019;

RX   PubMed=8704231;

RX   PubMed=9108419;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-B8

AC   CVCL_1713

SY   SupB8

DR   Cosmic; 910209

DR   Cosmic-CLP; 910209

DR   GDSC; 910209

DR   GEO; GSM1670491

RX   PubMed=2541219;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,12

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-HD1

AC   CVCL_2208

SY   Sup-HD1; SUP-HD-1; SUPHD1

DR   BioSample; SAMN03473483

DR   CCLE; SUPHD1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1086360

DR   Cosmic; 1278831

DR   Cosmic; 1432043

DR   Cosmic-CLP; 1331039

DR   DSMZ; ACC-574

DR   GDSC; 1331039

DR   GEO; GSM552469

DR   GEO; GSM887659

DR   GEO; GSM888751

DR   GEO; GSM1670492

RX   PubMed=2554995;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~40-80 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 10

ST   D5S818: 11,12

ST   D7S820: 10,12 (Cosmic-CLP)

ST   D7S820: 10,11,12 (DSMZ)

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-M2

AC   CVCL_2209

SY   SUPM2

DR   BTO; BTO:0004775

DR   BioSample; SAMN03473512

DR   CCLE; SUPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1086004

DR   Cosmic; 1152615

DR   Cosmic; 1995648

DR   Cosmic-CLP; 1331040

DR   DSMZ; ACC-509

DR   GDSC; 1331040

DR   GEO; GSM887660

DR   GEO; GSM888752

DR   GEO; GSM1670493

RX   PubMed=2525056;

RX   PubMed=15356658;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 8,12

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 16,18

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-M2-CR03

AC   CVCL_V405

SY   SUPM2CR03

DR   Cosmic; 1849570

RX   PubMed=23239810;

CC   Selected for resistance to: ChEBI; CHEBI:64310; Crizotinib (Xalkori).

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2209 ! SUP-M2

SX   Female

CA   Cancer cell line

//

ID   Sup-M2-TS

AC   CVCL_B228

SY   Sup-M2TS; TS

DR   BTO; BTO:0004867

DR   GEO; GSM1217149

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2209 ! SUP-M2

SX   Female

CA   Cancer cell line

//

ID   SUP-T1

AC   CVCL_1714

SY   Sup-T1; SUPT-1; SupT-1; Sup T-1; SUP T-1; SUP T1; Sup T1; SupT1; SUPT1; Tsup-1; VB; Stanford University Pediatric T-cell line 1

DR   BTO; BTO:0003582

DR   CLO; CLO_0009164

DR   CLDB; cl4420

DR   CLDB; cl4421

DR   CLDB; cl4422

DR   ATCC; CRL-1942

DR   BCRC; 60191

DR   BioSample; SAMN03471266

DR   BioSample; SAMN03473416

DR   CCLE; SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308368

DR   ChEMBL-Targets; CHEMBL614940

DR   Cosmic; 687855

DR   Cosmic; 909743

DR   Cosmic; 1086322

DR   Cosmic; 1281384

DR   Cosmic; 1330493

DR   Cosmic; 1524822

DR   Cosmic; 1664528

DR   Cosmic; 1760532

DR   Cosmic; 2165716

DR   Cosmic-CLP; 909743

DR   DSMZ; ACC-140

DR   ECACC; 95013123

DR   GDSC; 909743

DR   GEO; GSM482493

DR   GEO; GSM887662

DR   GEO; GSM888754

DR   GEO; GSM1670494

DR   ICLC; HTL96007

DR   NIH-ARP; 100-322

DR   NIH-ARP; 150-147

RX   PubMed=3004618;

RX   PubMed=3010463;

RX   PubMed=3036367;

RX   PubMed=3107838;

RX   PubMed=3935328;

RX   PubMed=6437672;

RX   PubMed=6438800;

RX   PubMed=7849311;

RX   PubMed=9933131;

RX   PubMed=22460905;

RX   PubMed=22675565;

RX   PubMed=25355872;

RX   PubMed=27397505;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0024&theme=default

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Characteristics: Useful in studies of cell fusion and cytopathic effects of HIV-1 as well as cytopathic isolates of HIV-2.

CC   Characteristics: Has chromosomal translocations involving the genes for the alpha and beta subunits of TCR thus preventing surface expression of the endogenous TCR complex.

CC   Doubling time: ~30 hours (DSMZ); ~24-36 hours (NIH-ARP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP)

ST   Amelogenin: X (DSMZ)

ST   CSF1PO: 10,11

ST   D13S317: 11,12 (ATCC; Cosmic-CLP)

ST   D13S317: 10,11,12 (DSMZ)

ST   D16S539: 9,11,12 (ATCC; Cosmic-CLP)

ST   D16S539: 9,10,11 (DSMZ)

ST   D5S818: 11,12 (ATCC; Cosmic-CLP)

ST   D5S818: 10,11,12 (DSMZ)

ST   D7S820: 11

ST   TH01: 9.3

ST   TPOX: 9 (ATCC; Cosmic-CLP)

ST   TPOX: 8,9 (DSMZ)

ST   vWA: 16,18 (ATCC; Cosmic-CLP)

ST   vWA: 16,18,19 (DSMZ)

DI   NCIt; C7210; Childhood T lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Sup-T1-CCR5

AC   CVCL_X633

SY   SupT1/CCR5

CC   Transfected with: HGNC; 1606; CCR5.

DI   NCIt; C7210; Childhood T lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1714 ! SUP-T1

SX   Male

CA   Cancer cell line

//

ID   Sup-T1/JI

AC   CVCL_M773

SY   SUP-T1/JI

DR   NIH-ARP; 12184-411

DI   NCIt; C7210; Childhood T lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1714 ! SUP-T1

SX   Male

CA   Cancer cell line

//

ID   SUP-T1/Z29

AC   CVCL_M772

SY   SUPT-1 / Z29

DR   NIH-ARP; 12183-349

RX   PubMed=11689646;

DI   NCIt; C7210; Childhood T lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1714 ! SUP-T1

SX   Male

CA   Cancer cell line

//

ID   SUP-T10

AC   CVCL_F689

SY   Stanford University Pediatric T-cell line 10

RX   PubMed=2786436;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T11

AC   CVCL_2210

SY   SupT11; SUPT-11; Stanford University Pediatric T-cell line 11

DR   BioSample; SAMN03473500

DR   CCLE; SUPT11_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 913418

DR   Cosmic; 1115599

DR   Cosmic; 1151792

DR   Cosmic; 1524823

DR   DSMZ; ACC-605

DR   GEO; GSM887661

DR   GEO; GSM888753

RX   PubMed=2786436;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~35-45 hours (DSMZ).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,12

ST   D16S539: 11,13

ST   D5S818: 13

ST   D7S820: 9,12

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T12

AC   CVCL_F691

SY   Stanford University Pediatric T-cell line 12

RX   PubMed=2786436;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T13

AC   CVCL_9973

SY   Sup-T13; SupT13; SUPT13; SUPT-13; Stanford University Pediatric T-cell line 13

DR   Cosmic; 913417

DR   Cosmic; 1115600

DR   Cosmic; 1151793

DR   Cosmic; 1760533

DR   Cosmic; 2165709

RX   PubMed=1720549;

RX   PubMed=2786436;

RX   PubMed=22675565;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-T14

AC   CVCL_F692

SY   Stanford University Pediatric T-cell line 14

RX   PubMed=2786436;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T19

AC   CVCL_9974

SY   Sup-T19; SUPT19; SupT19; Stanford University Pediatric T-cell line 19

RX   PubMed=1720549;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SUP-T2

AC   CVCL_F693

SY   Stanford University Pediatric T-cell line 2

RX   PubMed=3004618;

RX   PubMed=6437672;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-T3

AC   CVCL_F694

SY   Stanford University Pediatric T-cell line 3

RX   PubMed=3004618;

RX   PubMed=6437672;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T4

AC   CVCL_F695

SY   Stanford University Pediatric T-cell line 4

RX   PubMed=3004618;

RX   PubMed=6437672;

RX   PubMed=6438800;

DI   NCIt; C7226; Adult T lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T5

AC   CVCL_F686

SY   Stanford University Pediatric T-cell line 5

RX   PubMed=2786436;

DI   NCIt; C9360; Lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T6

AC   CVCL_F687

SY   Stanford University Pediatric T-cell line 6

RX   PubMed=2786436;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T7

AC   CVCL_A449

SY   SUPT7; SupT7; Stanford University Pediatric T-cell line 7

DR   Cosmic; 1115595

DR   Cosmic; 1151794

DR   Cosmic; 2396143

RX   PubMed=1967982;

RX   PubMed=2786436;

RX   PubMed=3162254;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUP-T8

AC   CVCL_F685

SY   Stanford University Pediatric T-cell line 8

RX   PubMed=2786436;

RX   PubMed=2875799;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SUP-T9

AC   CVCL_F688

SY   Stanford University Pediatric T-cell line 9

RX   PubMed=2786436;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SupB15RT

AC   CVCL_DR65

DR   PRIDE; PXD000394

RX   PubMed=25576301;

CC   Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).

CC   Omics: HLA class I peptidome analysis by proteomics.

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0103 ! SUP-B15

SX   Male

CA   Cancer cell line

//

ID   Super Dome

AC   CVCL_6452

SY   MDCK superdome

DR   ATCC; CRL-2286

DR   CCRID; 3111C0001CCC000225

RX   PubMed=21982418;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Super Tube

AC   CVCL_6453

SY   MDCK supertube

DR   ATCC; CRL-2285

RX   PubMed=21982418;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Super-CHO C1

AC   CVCL_IR03

SY   Super-CHO clone C1; CHO-IGF/Tf C1

RX   Patent=US6797515;

RX   PubMed=22358924;

CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.

CC   Doubling time: 18 hours (PubMed=19003411).

CC   Transfected with: HGNC; 5464; IGF1.

CC   Transfected with: HGNC; 11740; TF.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Super-CHO C2

AC   CVCL_IR04

SY   Super-CHO clone C2; CHO-IGF/Tf C2

RX   Patent=US6797515;

RX   PubMed=22358924;

CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.

CC   Doubling time: 21 hours (PubMed=19003411).

CC   Transfected with: HGNC; 5464; IGF1.

CC   Transfected with: HGNC; 11740; TF.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Super-CHO C2.8

AC   CVCL_IR05

SY   Super-CHO clone C2.8; C2.8

RX   PubMed=19003411;

RX   DOI=10.1002/jctb.1670;

CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.

CC   Transfected with: HGNC; 5464; IGF1.

CC   Transfected with: HGNC; 11740; TF.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_IR04 ! Super-CHO C2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Super-CHO ISS9

AC   CVCL_IR06

SY   Super-CHO clone ISS9; ISS9

RX   PubMed=19003411;

CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.

CC   Transfected with: HGNC; 5464; IGF1.

CC   Transfected with: HGNC; 11740; TF.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SURE CHO-M

AC   CVCL_R728

SY   CHO-M; CHOM

WW   http://www.selexis.com/#!sure-cho-m-cell-line/ctak

WW   http://www.selexis.com/#!sure-cho-m-genome/c1gti

CC   Omics: Genome sequenced.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SuSa

AC   CVCL_L280

SY   SUSA

DR   DSMZ; ACC-747

DR   GEO; GSM863899

RX   PubMed=593370;

RX   PubMed=6169654;

CC   Doubling time: ~48-72 hours (DSMZ).

ST   Source(s): DSMZ; PubMed=11416159

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 12,14

ST   D21S11: 29

ST   D5S818: 12,13

ST   D7S820: 11

ST   D8S1179: 15

ST   FGA: 21,21.2

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3877; Testicular teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SUSM-1

AC   CVCL_4903

SY   SUSM1

DR   CLO; CLO_0050043

DR   BioSample; SAMN03472342

DR   RCB; RCB0174

RX   PubMed=3413074;

RX   PubMed=8105370;

RX   PubMed=8148305;

RX   PubMed=8557247;

RX   PubMed=9175740;

RX   PubMed=9290701;

CC   Transformant: ChEBI; CHEBI:16907; 4-nitroquinoline N-oxide (4NQO).

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M811 ! AD387

SX   Male

CA   Transformed cell line

//

ID   SV

AC   CVCL_E938

DR   JCRB; JCRB1207

RX   PubMed=27844419;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   SV-3Y1-C66

AC   CVCL_F822

SY   SV-3Y1

DR   JCRB; JCRB0735

DR   RCB; RCB0343

RX   PubMed=2961438;

RX   PubMed=3533570;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_E147 ! 3Y1-B clone 1-6

SX   Female

CA   Transformed cell line

//

ID   SV-A3

AC   CVCL_0540

DR   MCCL; MCC:0000441

RX   PubMed=11387343;

CC   Transformant: Ad-SV40.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SV-AL/N

AC   CVCL_L813

SY   SVS AL/N

RX   PubMed=174816;

RX   PubMed=4302577;

RX   PubMed=4331720;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: AL/N.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6312 ! AL/N

CA   Transformed cell line

//

ID   SV-BR-1

AC   CVCL_4U12

SY   SV-BR1

DR   ATCC; PTA-7812

RX   Patent=US7674456;

RX   PubMed=16958969;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SV-BR-1-GM

AC   CVCL_4U13

SY   SVBR-1-GM

DR   ATCC; PTA-7813

RX   Patent=US7674456;

RX   PubMed=16958969;

CC   Transfected with: HGNC; 2434; CSF2.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4U12 ! SV-BR-1

SX   Female

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。